Wells Fargo analyst Mike Mayo maintains U.S. Bancorp (NYSE:USB) with a Overweight and lowers the price target from $70 to $60.
Conformis Actera Hip System Receives 510(k) Clearance From The U.S. FDA
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced that it has received 510(k) clearance from the U.S. Food and Drug
